Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 10/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ADH1B | P00325 | 1/20 | 0.44 |
| ▸ | ADH1C | P00326 | 1/20 | 0.44 |
| ▸ | ADH1A | P07327 | 1/20 | 0.44 |
| ▸ | ADH4 | P08319 | 1/20 | 0.44 |
| ▸ | ADH7 | P40394 | 1/20 | 0.44 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 2/20 | 0.39 |
| ▸ | GBA1 | P04062 | 1/20 | 0.38 |
| ▸ | CASP2 | P42575 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL983390 | 1.00 | EPHX1 (0.50) | EPHX1TSHRALDH1A1THRBADH1B | |
| SCHEMBL668300 | 1.00 | EPHX1 (0.50) | EPHX1TSHRALDH1A1THRBADH1B | |
| SCHEMBL7777014 | 1.00 | EPHX1 (0.50) | EPHX1TSHRALDH1A1THRBADH1B | |
| SCHEMBL7776706 | 1.00 | EPHX1 (0.50) | EPHX1TSHRALDH1A1THRBADH1B | |
| SCHEMBL5508330 | 1.00 | EPHX1 (0.50) | EPHX1TSHRALDH1A1THRBADH1B | |
| SCHEMBL5504517 | 1.00 | EPHX1 (0.50) | EPHX1TSHRALDH1A1THRBADH1B | |
| SCHEMBL15171894 | 1.00 | EPHX1 (0.50) | EPHX1TSHRALDH1A1THRBADH1B | |
| SCHEMBL41714 | 1.00 | EPHX1 (0.50) | EPHX1TSHRALDH1A1THRBADH1B | |
| SCHEMBL8421553 | 1.00 | EPHX1 (0.50) | EPHX1TSHRALDH1A1THRBADH1B | |
| SCHEMBL7174533 | 1.00 | EPHX1 (0.50) | EPHX1TSHRALDH1A1THRBADH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110530055-B | Absorption type water chiller/heater, refill liquid for absorption type water chiller/heater, absorption liquid for absorption type water chiller/heater, and maintenance method | 株式会社克莱瑞斯 | 2021-08-20 | — | — | CN | claimed |
| US-20250019482-A1 | SYNTHESIS AND FABRICATION OF MECHANICALLY ROBUST AND MESOPOROUS ABAC TETRABLOCK POLYMER MEMBRANES FOR ULTRAFILTRATION | U.S. DEPARTMENT OF ENERGY | 2025-01-16 | — | — | US | disclosed |
| CN-115667626-B | Microfibrous cellulose, dispersion, sheet, laminate, and process for producing microfibrous cellulose | 王子控股株式会社 | 2025-01-10 | — | — | CN | disclosed |
| US-20240025878-A1 | MDM2 DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2024-01-25 | — | — | US | disclosed |
| US-20230365563-A1 | QUINAZOLINE COMPOUND AND APPLICATION THEREOF | SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) | 2023-11-16 | — | — | US | disclosed |
| US-20220152196-A1 | SAPONIN-BASED VACCINE ADJUVANTS | THE UAB RESEARCH FOUNDATION | 2022-05-19 | — | — | US | disclosed |
| CN-112654746-B | Fibrous cellulose-containing material, fluffed cellulose, and composition | 王子控股株式会社 | 2022-04-29 | — | — | CN | disclosed |
| CN-111373000-B | Resin composition containing fibrous cellulose, sheet and molded body | 王子控股株式会社 | 2022-02-25 | — | — | CN | disclosed |
| CN-110530055-B | Absorption type water chiller/heater, refill liquid for absorption type water chiller/heater, absorption liquid for absorption type water chiller/heater, and maintenance method | 株式会社克莱瑞斯 | 2021-08-20 | — | — | CN | disclosed |
| CN-110530055-B | Absorption type water chiller/heater, refill liquid for absorption type water chiller/heater, absorption liquid for absorption type water chiller/heater, and maintenance method | 株式会社克莱瑞斯 | 2021-08-20 | — | — | CN | disclosed |
| US-20120046244-A1 | DUAL FUNCTIONING IONIC LIQUIDS AND SALTS THEREOF | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2012-02-23 | — | — | US | disclosed |
| WO-2012006313-A2 | HERBICIDAL COMPOSITIONS AND METHODS OF USE | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2012-01-12 | — | — | WO | disclosed |
| WO-2010078300-A1 | DUAL FUNCTIONING IONIC LIQUIDS AND SALTS THEREOF | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2010-07-08 | — | — | WO | disclosed |
| US-20100021695-A1 | ENGRAVED PLATE AND SUBSTRATE WITH CONDUCTOR LAYER PATTERN USING THE SAME | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2010-01-28 | — | — | US | disclosed |
| EP-2098362-A1 | ENGRAVED PLATE AND BASE MATERIAL HAVING CONDUCTOR LAYER PATTERN USING THE ENGRAVED PLATE | Hitachi Chemical Company, Ltd. (JP) | 2009-09-09 | — | — | EP | disclosed |
| EP-1931760-A2 | MULTI-FUNCTIONAL IONIC LIQUID COMPOSITIONS | The University of Alabama (US) | 2008-06-18 | — | — | EP | disclosed |
| US-20080031906-A1 | Cosmetic Composition and Method for Producing the Same | HAKUTO CO., LTD. (JP) | 2008-02-07 | — | — | US | disclosed |
| EP-1820538-A1 | COSMETICS AND PROCESS FOR PRODUCTION THEREOF | Hakuto Co., Ltd (JP) | 2007-08-22 | — | — | EP | disclosed |
| US-20070093462-A1 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA | 2007-04-26 | — | — | US | disclosed |
| WO-2007044693-A2 | MULTI-FUNCTIONAL IONIC LIQUID COMPOSITIONS | THE UNIVERSITY OF ALABAMA (US) | 2007-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093462-A1 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | SLC5A6, PNLIP, IPMK | EPHX1 3269/4885TSHR 4253/4885ALDH1A1 2937/4885 |
| US-20240025878-A1 | MDM2 DEGRADERS AND USES THEREOF | MDM2, TP53, MDM4 | EPHX1 2320/4885TSHR 3455/4885ALDH1A1 1804/4885 |
| US-20080031906-A1 | Cosmetic Composition and Method for Producing the Same | LIPA, CUTA, PLIN3 | EPHX1 1435/4885TSHR 1851/4885ALDH1A1 3364/4885 |
| US-20230365563-A1 | QUINAZOLINE COMPOUND AND APPLICATION THEREOF | KRAS, NRAS, BRAF | EPHX1 4256/4885TSHR 4687/4885ALDH1A1 3174/4885 |
| US-20120046244-A1 | DUAL FUNCTIONING IONIC LIQUIDS AND SALTS THEREOF | SLC6A6, SLC10A2, CLK2 | EPHX1 4482/4885TSHR 3455/4885ALDH1A1 3146/4885 |
| US-20220152196-A1 | SAPONIN-BASED VACCINE ADJUVANTS | ST3GAL3, B3GAT3, CSGALNACT1 | EPHX1 2474/4885TSHR 3151/4885ALDH1A1 4710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.